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Upon maturation, natural killer (NK) cells acquire effector functions and regulatory
receptors. New insights suggest a considerable functional heterogeneity and dynamic
regulation of receptor expression in mature human NK cell subsets based on different
developmental axes. Such processes include acquisition of lytic granules as well as
regulation of cytokine production in response to exogenous cytokine stimulation or target
cell interactions. One axis is regulated by expression of inhibitory receptors for self-MHC
class I molecules, whereas other axes are less well defined but likely are driven by
different activating receptor engagements or cytokines. Moreover, the recent identification
of long-lived NK cell subsets in mice that are able to expand and respond rapidly following a
secondary viral challenge suggest previously unappreciated plasticity in the programming
of NK cell differentiation. Here, we review advances in our understanding of mature NK cell
development and plasticity with regards to regulation of cellular function. Furthermore, we
highlight some of the major questions that remain pertaining to the epigenetic changes
that underlie the differentiation and functional specialization of NK cells and the regulation
of their responses.
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INTRODUCTION
Epigenetics refers to functionally relevant modifications to the
genome that do not involve a change in the nucleotide sequence,
but may impact gene expression, cellular phenotype, and func-
tion. Examples of such modifications are acetylation, methylation
or phosphorylation of the N-terminal tails of histone proteins.
In general, acetylation marks are enriched in open chromatin
regions, while histone methylation associates with either open or
closed chromatin depending on the degree of methylation and
the specific amino acid residues that are modified on the histone
proteins (Suganuma andWorkman, 2011). Changes in chromatin
structure also occur through DNA methylation and demethy-
lation, nucleosome repositioning and the generation of DNase
hypersensitive sites. Conclusive evidence has demonstrated that
epigenetic changes that take place during cell differentiation can
persist through multiple cell divisions (Greer and Shi, 2012).
Natural killer (NK) cells constitute an arm of the innate
immune system, as their effector functions are controlled by a
repertoire of germline–encoded receptors that do not undergo
somatic recombination (Lanier, 2008; Bryceson et al., 2011).
However, similar to other lymphocyte subsets such as T and
B cells, NK cells may manifest adaptive features including
enhanced longevity and recall responses (Sun and Lanier, 2011).
NK cells produce interferon (IFN)-γ in response to exoge-
nous cytokines, display immunoregulatory activity in regards to
perforin-dependent killing of activated immune cells andmediate
immunosurveillance and elimination of intracellular pathogens
and tumors through both IFN-γ secretion and target cell killing
(Lodoen and Lanier, 2006; Vesely et al., 2011). From a clini-
cal perspective, NK cells can kill allogeneic cells in the setting
of hematopoietic stem cell transplantation and are utilized in
immunotherapy for the treatment of certain malignancies (Geller
and Miller, 2011).
Considerable heterogeneity exists among human peripheral
blood NK cells with regards to phenotype and function, and a
hierarchy of activating stimuli controls the induction of various
effector functions (Bjorkstrom et al., 2010; Fauriat et al., 2010;
Juelke et al., 2010) (Figure 1). Although many details are lacking,
experimental evidence suggests that NK cell precursors develop
in primary lymphoid organs, circulate through the bloodstream,
and collect in secondary lymphoid tissues. During the maturation
process, NK cells differentiate into highly proliferative CD56bright
NK cells. Terminal differentiation involves a downregulation of
CD56, changes in the receptor profile and acquisition of cytotoxic
function (Freud et al., 2005). In parallel to the continuous matu-
ration process, recognition of major histocompatibility complex
(MHC) class I molecules by inhibitory receptors potentiate NK
cell responses through a phenomenon known as education (Kim
et al., 2005; Anfossi et al., 2006). The expression levels of several
surface proteins on CD56dim NK cells including CD57, CD62L,
and CD94 correlate either positively or negatively with differen-
tiation as defined by cytotoxic potential (Bjorkstrom et al., 2010;
Juelke et al., 2010; Yu et al., 2010), but no cellular marker has been
identified to distinguish between educated and non-educated NK
cells. Further highlighting cellular plasticity, phenotypically and
functionally distinct NK cell subsets are found in the uterus, liver,
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FIGURE 1 | Checkpoints in NK cell development. As NK cells develop, they
transit through the body and advance through checkpoints that are controlled
by DNA-binding factors. Throughout this process, the expression of
developmental markers, cytokine receptors, natural cytotoxicity receptors,
and functional competencies are all dynamically regulated resulting in
considerable heterogeneity within the NK cell population. Protein expression
data are modified from (Freud et al., 2005; Freud and Caligiuri, 2006) and for
“memory” NK cells extrapolated from (Sun et al., 2009; Hwang et al., 2012).
mucosa, and lymph nodes (Koopman et al., 2003; Cella et al.,
2009; Luci et al., 2009). Defining NK cell subsets and under-
standing the acquisition of function is particularly difficult since
superimposing differentiation and education processes on NK
cell functionality does not fully explain the heterogeneity in NK
cell responses. Here, we provide an overview of current insights
into the transcriptional and epigenetic regulation of mature NK
cell development and differentiation.
TRANSCRIPTION FACTORS IMPLICATED IN DEVELOPMENT
AND DIFFERENTIATION OF MATURE NK CELLS
Cellular identity is formed and often maintained by a network of
transcription factors that influence the chromatin state and drive
gene expression patterns. Mouse models have been instrumental
for identifying several key transcription factors that are neces-
sary for commitment to the NK cell lineage. Signaling through
the interleukin-15 receptor common beta and gamma chains
(CD122/132) is essential for NK cell development, and con-
ditional knockout of Stat5a and Stat5b in NK cells results in
an almost complete developmental block at the NK progenitor
(NKP) to immature NK (iNK) transition (Eckelhart et al., 2011).
Moreover, autosomal recessive STAT5B mutations in humans
are associated with defective NK cell development and severe
herpes virus infections (Kofoed et al., 2003). STAT5 proteins
can enhance cell survival by driving expression of important
anti-apoptotic genes such as Bcl-2, Bcl-xL , and Mcl-1 (Debierre-
Grockiego, 2004) or by inducing activation of the phosphoinostol
3-kinase (PI3K)/Akt and Ras/MAPK pathways (Nyga et al., 2005).
While these pathways may contribute to NK cell development,
Gascoyne et al. recently discovered an axis in which IL-15R sig-
naling is necessary, specifically in NK cells, for the expression of
the transcription factor E4bp4 (Gascoyne et al., 2009). As NKP
cells transition to the iNK stage, E4bp4 induces transcription of
Id2 and Gata3, which are critical for further NK cell develop-
ment. The generation of mice with targeted mutations in putative
Stat5 binding sites within the regulatory regions E4bp4 are needed
to definitively determine whether the requirement for Stat5 pro-
teins in NK cell development is through direct induction of E4bp4
expression. A second axis involved in the control of early NK cell
development is dependent upon the transcription factor thymo-
cyte selection-associated high-mobility group box protein (TOX).
NK cells in Tox-deficient mice fail to develop from iNK to mature
NK (mNK) cells (Aliahmad et al., 2010). Although Id2 expres-
sion is slightly lower in Tox-deficient NK cells, overexpression of
Id2 in these cells cannot rescue the developmental block. Tox-
deficient NKPs also express normal levels of IL-15R, suggesting
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that TOX acts in a separate pathway to promote early NK cell
development.
The homologous transcription factors Tbx21 (T-bet) and
Eomes are essential components of another early pathway that
regulates NK cell development. NK cell-specific deletion of Tbx21
leads to a block in development at the transition between the NKP
and iNK stages of development, while deletion of Eomes causes
defects in subsequent maturation events including the acquisi-
tion of a diverse Ly49 receptor repertoire and expression of other
developmental markers including DX5. Interestingly, sustained
expression of both T-bet and Eomes appears to be essential for
maintaining the identity/maturity of NK cells (Gordon et al.,
2012), though the epigenetic basis for these observations is yet
to be explored. Knockout studies in mice have demonstrated that
several other transcription factors including Ets1, Spi1, and Irf2
have cell-intrinsic requirements for early NK cell development
(Scott et al., 1994; Barton et al., 1998; Lohoff et al., 2000). Spi1−/−
mice, which lack expression of the Ets-family transcription factor
PU.1, die in utero. Fetal liver transfer experiments have revealed
that PU.1-deficiency abrogates T and B cell development and
severely impairs the development of NK cell precursors (pre-NK)
(Colucci et al., 2001). Similarly, Gata3−/− mice die in utero, but
display normal NK cell numbers in the spleen.Gata3−/− NK cells
are more immature, suggesting a defect in iNK to mNK transi-
tion (Samson et al., 2003). Furthermore, Id2−/− mice are viable
and display a defect in iNK to mNK transition (Boos et al., 2007).
Mutations in GATA2 were recently identified in patients with a
syndrome known as dendritic cell, monocyte, B and natural killer
lymphoid (DCML)-deficiency (Dickinson et al., 2011; Hsu et al.,
2011), but whether NK cells have a cell-intrinsic requirement
for GATA2 expression or whether the NK cell-deficiency is sec-
ondary to the loss of monocytes and dendritic cells still needs to
be clarified.
While considerable progress has been made in identifying
transcription factor networks that control early developmental
checkpoints, much less is known with regards to how the termi-
nal maturation stages are regulated in NK cells. Targeted exome
sequencing of individuals with a variant of familial glucocorticoid
deficiency (FGD) associated with severe herpes virus infections
uncovered an essential role for the minichromosome mainte-
nance (MCM) 4 gene NK cell terminal differentiation (Gineau
et al., 2012). MCM4 is a component of a protein complex with
DNA helicase activity that acts in separating DNA strands during
replication. NK cells from patients with partial MCM4-deficiency
failed to efficiently differentiate beyond the CD56bright stage and
did not proliferate in response to IL-2 or IL-15, suggesting that
robust proliferation is necessary for the CD56bright to CD56dim
NK cell transition. It is remarkable that the proliferation of B and
T cells was not affected in patients with MCM4-deficiency, and
more studies are required to explain why the observed prolifera-
tion defects are specific to NK cells, whether MCM4-deficiency
affects differentiation or survival and to rule out the possibil-
ity that the adrenal insufficiency in these patients is impacting
NK cell development. Regardless of the mechanistic details, these
studies highlight the uniqueness of the CD56bright NK cell sub-
set and demonstrate the importance of proliferation in NK cell
development and differentiation.
EVIDENCE FOR EPIGENETIC REGULATION OF MATURE NK
CELL FUNCTION
Although NK cell activation has been studied intensively for
several decades, the mechanisms underlying the generation and
maintenance of functional NK cells remains only partially under-
stood. The effector molecule that is most highly associated with
NK cell cytotoxicity is perforin, which creates pores in the phos-
pholipid bilayer of target cells, facilitating entry of apoptosis-
inducing granzymes. Expression of the Ets family transcription
factor myeloid Elf1-like factor (MEF) directly binds to two sites
within the PRF1 promoter and is obligatory for perforin expres-
sion in NK cells but not CD8+ T cells, demonstrating that PRF1
expression is differentially regulated at the transcriptional level in
cytotoxic lymphocytes. The 5′ regulatory region of PRF1 contains
two enhancers, located at −15 and −1 kb that bind Stat5 and are
responsive to IL-2R-activated signal transduction (Zhang et al.,
1999). The importance of these enhancers is evident in NK cells
from Il2Rb or Stat5b knockout mice that have significantly lower
levels of perforin transcription (Imada et al., 1998). Interestingly,
the −1 kb enhancer is also responsive to IL-6 and IL-12 and can
bind STAT1a and STAT4, respectively, upon cytokine stimulation
(Yu et al., 1999; Yamamoto et al., 2002). How these enhancers and
other known regulatory elements within PRF1 are regulated dur-
ing NK cell development and whether they contribute to DNA
demethylation within the locus remains to be determined.
Granzymes constitute a family of serine proteases that are
found in cytolytic granules of cytotoxic T cells and NK cells.
One of the most thoroughly studied members of the family
is granzyme B, which can mediate target cell death through
the cleavage of caspases or through damage to the mitochon-
dria (Lieberman, 2003). Studies on transcriptional control of
granzyme B expression in CD8+ T cells have demonstrated that
several transcription factors including AP1, IKAROS, RUNX1,
CREB1, and Eomes bind within a large DNase-hypersensitive
region comprising the granzyme B promoter and facilitate tran-
scription (Wargnier et al., 1995; Babichuk et al., 1996; Araki
et al., 2008). Little is known with regards to epigenetic control
of granzyme B expression outside of the observation that histone
H3K9 acetylation within the granzyme B promoter correlates
with high levels of gene expression (Araki et al., 2008). Signaling
through the NF-κB pathway induces granzyme B expression,
and NF-κB binds to a putative enhancer element approximately
10 kb downstream of the transcriptional start site (Huang et al.,
2006). Further studies are needed to test whether this enhancer
promotes expression by influencing the chromatin environment
surrounding GZMB.
The mechanisms that regulate IFN-γ production are of inter-
est given that a tight balance must be maintained to ensure that
enough IFN-γ is produced to bolster immune responses without
an overproduction that can lead to severe and widespread pathol-
ogy. In this regard, CD56bright NK cells produce IFN-γ mainly
in response to exogenous cytokines, whereas CD56dim NK cells
do so mainly in response to target cells. Furthermore, IFN-γ
production by donor NK cells is also impaired following trans-
plantation (Foley et al., 2011). Rapid production of IFN-γ by NK
cells upon stimulation appears to be due, at least in part, to the
establishment of long-range histone acetylation patterns at distal
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conserved non-coding sequences (CNS) within the IFNG locus
early during NK cell development. Several CNS elements have
been identified in both the human and mouse genes. Of note, a
CNS element ∼22 kb upstream of murine Ifng binds T-bet and
serves as an obligate enhancer for opening the locus and allowing
expression in NK cells (Hatton et al., 2006).
The binding of several cytokines, including IL-2, IL-15, IL-12,
and IL-18, to their cognate receptor complexes on NK cells
strongly induces IFN-γ expression. In primary human NK cells,
IL-2 treatment enhances histone acetylation at a DNase-I hyper-
sensitivity region containing a Stat5 binding site ∼3.5–4.0 kb
upstream of the transcriptional start site. Thus, this distal regu-
latory element is a target of chromatin remodeling in the IFNG
locus and acts as an IL-2-responsive transcriptional enhancer
(Bream et al., 2004). Since CD56bright NK cells constitutively
express both the high- and intermediate-affinity IL-2R chains
(Matos et al., 1993), the presence of the ∼3.5–4.0 kb upstream
element provides a presumptive explanation for the enhanced
ability of CD56bright NK cells to produce IFN-γ in response to
IL-2 relative to the CD56dim subset.
Changes in nucleosome composition or position are also
important for the establishment of open chromatin and active
transcription. So far, three distinct chromatin-remodeling com-
plexes have been identified in mammals. These include the
Mi-2-NuRD complex, the ISWI complex, and a mammalian
Switch (Swi)-sucrose non-fermenter (SNF) homologue complex
(Narlikar et al., 2002). The mammalian Swi-SNF complex con-
tains a homologue of Brahma-related gene 1 (Brg1) or Brahma
and includes Brahma/Brg1-associated factors that are capable of
binding DNA (Khavari et al., 1993). In Th1 cells, Stat4-dependent
recruitment of Brg1 is necessary for nucleosome remodeling
within the first 600 bases of the Ifng promoter (Zhang and
Boothby, 2006). Whether Stat4 recruits Brg1 through a direct
interaction or indirectly by promoting histone acetylation and
creating favorable conditions for Brg1 binding is still unknown.
A similar mechanism presumably controls IFN-γ expression in
CD56dim NK cells, which express high levels of both Brg1 and
STAT4 (Cichocki and Bryceson, unpublished observations). How
the IFNG locus may be distinctly regulated in CD56bright and
CD56dim NK cells to control IFN-γ production induced by exoge-
nous cytokines or target cell recognition may provide interesting
insights into the mechanisms regulating functional specialization
of NK cell subsets.
In addition to IFN-γ, CD56dim NK cells produce high lev-
els of tumor necrosis factor (TNF)-α in response to target cell
stimulation, which has a major role in initiating inflammatory
responses, promoting the clearance of intracellular pathogens,
and killing tumors. TNF-α belongs to the TNF superfamily,
which also includes the proinflammatory cytokines lympho-
toxin (LT)-α and LT-β. The TNF/LT genes are clustered together
within the MHC class III region on human chromosome 6.
DNA within the 5′ regulatory region of TNF is densely methy-
lated in embryonic and hematopoietic precursor cells. Studies
using monocytes show that lineage commitment is associated
with DNA demethylation followed by the acquisition of his-
tone acetylation and the establishment of open chromatin. In
mouse monocyte cell lines, histones within the Tnf promoter
associate constitutively with Brg1 (Ramirez-Carrozzi et al., 2006).
Therefore, a common mechanism involving histone modifica-
tion and nucleosome repositioning is responsible for creating an
open chromatin conformation within the regulatory regions of
multiple inflammatory cytokine genes. Figure 2 summarizes the
current state of knowledge with regard to transcription factor
binding to PRF1, GZMB, IFNG, and TNF and epigenetic control
of their expression.
ADAPTIVE NK CELL RESPONSES AND EPIGENETIC
REGULATION
The term “memory” NK cell was first coined after the obser-
vation of long-lived NK cells following CMV infection in
mice (Sun et al., 2009). Such adaptive NK cells express self-
specific inhibitory Ly49 receptors and their expansion is Dap12-
dependent (Sun et al., 2009). Similarly, in humans, NK cells
expressing the DAP12-coupled activating receptor NKG2C are
found at high frequencies in CMV seropositive donors (Lopez-
Vergès et al., 2011; Foley et al., 2012). Moreover, in the context
of severe viral infections, NKG2C+ NK cells with self-specific
inhibitory KIR receptors expand (Bjorkstrom et al., 2011; Beziat
et al., 2012).
The formation of B and T cell memory involves antigen recog-
nition by the B cell receptor and T cell receptor complexes,
respectively, along with cytokine signaling and clonal expansion.
At the molecular level, programming of B and T cell memory
is dependent upon transcription factor networks that promote
differentiation and survival. Of note, the transcription factors B
cell lymphoma 6 (BCL-6) and PR domain-containing protein 1
(PRDM1) act within a regulatory axis to control effector and
memory differentiation in CD4+ T cells, CD8+ T cells, and B cells
by reinforcing cell-fate decisions (Crotty et al., 2010). The shared
requirement for BCL-6 and PRDM1 in the generation of adap-
tive immune memory make these transcription factors attractive
candidates for study in the emerging field of NK cell memory
formation.
The mechanisms that control NK cell proliferation and sur-
vival are highly relevant to “memory” NK cells. Studies of murine
NK cell responses to mouse cytomegalovirus (MCMV) revealed
that virus-specific NK cells proliferate 100-fold in the spleen and
1000-fold in the liver after infection. After the initial expansion
and contraction phases, a pool of self-renewing “memory” NK
cells with the ability to rapidly respond to secondary viral chal-
lenges persists for several months (Sun et al., 2009). This adaptive
NK cell population can develop in Ifng-deficient mice, but fails to
develop in either Il12r or Stat4-deficient mice (Sun et al., 2012).
The precise role of STAT4 in the generation of “memory” NK cells
remains to be elucidated, but studies of memory formation in
CD8+ T cells may provide some clues. STAT4 activation down-
stream of IL-12 promotes clonal expansion of antigen-specific
CD8+ T cells by enhancing expression of the anti-apoptotic genes
Bcl2 and Bcl-xL and increasing sensitivity to IL-7 and IL-15 (Li
et al., 2006). Moreover, “memory” NK cells in mice vigorously
produce IFN-γ and TNF-α in response to ITAM-receptor stimu-
lation. The same phenomenon is observed in a subset of human
NK cells with down-regulated FcεRγ-expression (Hwang et al.,
2012). At present, data suggest that only educated cells proliferate
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FIGURE 2 | Transcriptional and epigenetic regulation of key effector molecules. Proposed models for the regulation of perforin, granzyme B, IFN-γ, and
TNF-α expression at the transcriptional level through transcription factor binding and changes in the chromatin state.
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FIGURE 3 | Proposed models for the generation of “memory” NK cells
during a viral infection vs. cytokine priming. (A) The generation of
“memory” NK cells during a viral infection likely happens within the context
of NK cell education, where an “educated” NK cell expands during a viral
infection and exhibits rapid cytotoxicity and inflammatory cytokine production
upon a secondary challenge. (B) The generation of “memory” NK cells as a
result of cytokine stimulation may result in epigenetic priming of the IFNG
locus and/or accumulation of IFN-γ transcripts in the nucleus. This process
may be fundamentally different from the generation of “memory” NK cells
during a viral infection.
in response to cytokines and signals from DAP12-coupled recep-
tors (Figure 3). However, many open questions remain with
respect to how NK cell function relates to development and the
extent to which NK cell differentiation is linear vs. branched. The
application of high-throughput sequencing technologies to study
distinct subsets of NK cells could be very useful in elucidating
the processes that regulate differentiation and the acquisition of
function.
Also pertaining to stimulation induced changes in NK cell
responsiveness, two recent reports described the generation of
“memory” NK cells after in vitro stimulation with combinations
of IL-12, IL-18, and IL-15 (Cooper et al., 2009; Romee et al.,
2012). In both mouse and human systems, NK cells were primed
with cytokines and restimulated at later time points. Cells that
were primed demonstrated a more robust IFN-γ response with-
out any enhancement in cytotoxicity upon restimulation with
either exogenous cytokines or through activating receptors. These
adaptive responses were identified primarily in humanCD56bright
NK cells and CD56dim NK cells lacking the expression of killer
immunoglobulin-like receptors (KIR) and CD57, and might sim-
ply reflect epigenetic changes at the IFNG locus. An alternative
explanation for these results is that the priming of NK cells with
IL-12, IL-18, and IL-15 selectively affects the post-transcriptional
regulation of IFN-γmRNA. Previous studies have shown that co-
stimulation of NK cells with IL-2 and IL-12 leads to enhanced
mRNA stabilization (Ye et al., 1995). However, IL-12 stimulation
is unique in that it causes an elevation in nuclear IFN-γ mRNA
retention after transcriptional activity of the gene has ceased,
which is likely directed by specific sequence elements within the
IFN-γ mRNA transcript. The nuclear retention of IFN-γ mRNA
transcripts can be overcome by co-stimulation with IL-2, which
leads to transcription-independent transport of IFN-γ mRNA
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out of the nucleus and into the cytoplasm where it can be
translated (Hodge et al., 2002). Enhanced cytokine responses in
memory T cells correlate with changes in the chromatin state
of cytokine genes. These changes are stable and can be inher-
ited through cell divisions, forming the basis for memory. Future
studies should be done to compare the epigenetic changes associ-
ated with “memory” NK cells generated from cytokine priming to
“memory” NK cells generated from receptor engagement during
a viral infection, which exhibit more robust IFN-γ responses and
enhanced degranulation upon secondary challenge.
PERSPECTIVES AND FUTURE DIRECTIONS
A deeper understanding of NK cell differentiation and the spe-
cialization of function will ultimately require high-resolution,
genome-wide analyses. The development of the chromatin
immunoprecipitation (ChIP)-seq technique, which combines
ChIP and high-throughput sequencing methods, provides the
opportunity to directly assess histone modifications and DNA-
binding proteins. Combining ChIP-seq data with global gene
expression results from techniques such as microarrays or
RNA-seq makes it possible to produce a genome-wide view
that links chromatin state with transcriptional activity within a
defined population of cells. These technologies have been used
extensively to study T cell differentiation and the chromatin states
of genes that are selectively expressed in distinct populations of
memory cells. Limited numbers relative to other lymphocyte sub-
sets makes the application of high-throughput technologies to
primary NK cells difficult, but improvements in reagents and
sequencing sensitivity should soon overcome these obstacles. This
will provide new views of how NK cells differentiate and undergo
functional specialization.
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